Cingulate(CING) - 2022 Q4 - Annual Report

● product seizure or detention or refusal to permit the import or export of products; and 59 In addition, the FDA's or other regulatory authorities' policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our drug candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are otherwise not able to maintain regulatory compliance, we may lose any marketing ...